Aurobindo Pharma Incorporates New Subsidiary Avogent Lifesciences

Aurobindo Pharma Ltd announced the incorporation of its new wholly owned subsidiary, Avogent Lifesciences Private Limited, through its existing subsidiary Apitoria Pharma Private Limited. The new entity, established in India with an initial share capital of ₹5 crore, aims to undertake manufacturing and marketing operations both domestically and internationally. This move is part of Aurobindo's strategic expansion in the pharmaceutical sector. No governmental or regulatory approvals were required for this incorporation, and it is considered a related party transaction as per SEBI regulations.